Of these studies, 20 studies reporting 2120 cases and 2189 nonmalignant controls were calculated to assess the association between MGMT methylation and GC risk, and 17 studies reporting 1299 male GC patients and 775 female GC patients were used to evaluate the association between MGMT methylation and gender. This evidence concerns the gene MGMT and gastric cancer.